Filing Details
- Accession Number:
- 0001181431-11-058857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-05 19:50:07
- Reporting Period:
- 2011-12-05
- Filing Date:
- 2011-12-05
- Accepted Time:
- 2011-12-05 19:50:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178711 | Transcept Pharmaceuticals Inc | TSPT | Pharmaceutical Preparations (2834) | 330960223 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454351 | N Nikhilesh Singh | C/O Transcept Pharmaceuticals, Inc. 1003 W. Cutting Blvd, Suite 110 Point Richmond CA 94804 | Svp & Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-12-05 | 13,237 | $7.59 | 1,554 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-12-05 | 36,709 | $7.59 | 0 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 295 | Indirect | See footnote |
Common Stock | 78,206 | Indirect | See footnote |
Footnotes
- Shares held directly by the Nikhilesh and Nikki Singh Revocable Trust (the "Revocable Trust") for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Revocable Trust except to the extent of his pecuniary interest therein.
- Shares held directly by the Reporting Person's spouse.
- Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
- The sales price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold within an estimated range from $8.16 to $7.20 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.